Symonds; James Matthew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Symonds; James Matthew.The latest application filed is for "compounds and methods for modulating ve-cadherin-mediated function".

Company Profile

0.15.12

Symonds; James Matthew - Durham NC
Symonds; James Matthew - Ottawa CA
SYMONDS, JAMES MATTHEW - ONTARIO CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods for modulating OB-cadherin-mediated function Grant 7,481,999 - Blaschuk , et al. January 27, 2	2009-01-27
Compounds and methods for modulating nonclassical cadherin-mediated functions Grant 6,962,969 - Blaschuk , et al. November 8, 2	2005-11-08
Compounds and methods for modulating VE-cadherin-mediated function App 20050222037 - Blaschuk, Orest W. ; et al.	2005-10-06
Compounds and methods for modulating OB-cadherin-mediated function App 20050215482 - Blaschuk, Orest W. ; et al.	2005-09-29
Compounds and methods for modulating nonclassical cadherin-mediated functions App 20050203025 - Blaschuk, Orest W. ; et al.	2005-09-15
Compounds and methods for cancer therapy App 20050037973 - Blaschuk, Orest W. ; et al.	2005-02-17
Compounds and methods for modulating claudin-mediated functions Grant 6,830,894 - Blaschuk , et al. December 14, 2	2004-12-14
Methods for diagnosing and evaluating cancer App 20040248219 - Blaschuk, Orest W. ; et al.	2004-12-09
Methods for diagnosing and evaluating cancer App 20040248220 - Blaschuk, Orest W. ; et al.	2004-12-09
Compounds and methods for modulating desmosomal cadherin-mediated functions App 20040229811 - Blaschuk, Orest W. ; et al.	2004-11-18
Compounds and methods for cancer therapy Grant 6,797,807 - Blaschuk , et al. September 28, 2	2004-09-28
Compounds and methods for modulating claudin-mediated functions Grant 6,756,356 - Blaschuk , et al. June 29, 2	2004-06-29
Compounds and methods for modulating claudin-mediated functions Grant 6,723,700 - Blaschuk , et al. April 20, 2	2004-04-20
Methods for diagnosing and evaluating cancer Grant 6,682,901 - Blaschuk , et al. January 27, 2	2004-01-27
Methods for diagnosing and evaluating cancer Grant 6,680,175 - Blaschuk , et al. January 20, 2	2004-01-20
Compounds and methods for modulating nonclassical cadherin-mediated functions App 20030229199 - Blaschuk, Orest W. ; et al.	2003-12-11
Compounds and methods for modulating desmosomal cadherin-mediated functions Grant 6,638,911 - Blaschuk , et al. October 28, 2	2003-10-28
Compounds and methods for inhibiting cancer metastasis Grant 6,593,297 - Blaschuk , et al. July 15, 2	2003-07-15
Compounds and methods for inhibiting cancer metastasis App 20030096746 - Blaschuk, Orest W. ; et al.	2003-05-22
Compounds and methods for modulating junctional adhesion molecule-mediated functions App 20030027761 - Blaschuk, Orest W. ; et al.	2003-02-06
Compounds And Methods For Modulating Claudin-mediated Functions App 20020193294 - BLASCHUK, OREST W. ; et al.	2002-12-19
Compounds and methods for modulating OB-cadherin mediated cell adhesion Grant 6,472,367 - Blaschuk , et al. October 29, 2	2002-10-29
Methods For Diagnosing And Evaluating Cancer App 20020146687 - BLASCHUK, OREST W. ; et al.	2002-10-10
Compounds and methods for inhibiting cancer metastasis Grant 6,433,149 - Blaschuk , et al. August 13, 2	2002-08-13
Compounds and methods for modulating junctional adhesion molecule-mediated functions Grant 6,391,855 - Blaschuk , et al. May 21, 2	2002-05-21
Compounds and methods for modulating tissue permeability Grant 6,310,177 - Blaschuk , et al. October 30, 2	2001-10-30
Compounds and methods for modulating tissue permeability Grant 6,110,747 - Blaschuk , et al. August 29, 2	2000-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.